The global actinic keratosis treatment market is anticipated to grow at a significant CAGR of 5.0% during the forecast period 2022-2028. The rising incidence and prevalence rate of actinic keratosis is expected to propel the actinic keratosis treatment market forward. For instance, the information provided by the National Center for Biotechnology Information, in February 2019, which highlighted the fact that Australia had the highest frequency of actinic keratosis, with an estimated prevalence of 37%-55% in Australian individuals over the age of 40. Whereas in UK, 15% of males and 6% of females are affected. Elderly people are also more susceptible to the development of actinic keratosis. As a result, the global actinic keratosis therapy market is being fuelled by the growing geriatric population. However, the high cost of treating actinic keratosis and the restricted treatment alternatives available may hinder the market’s global expansion.
Get Free Sample link @ https://www.omrglobal.com/request-sample/actinic-keratosis-treatment-market-share
The COVID-19 pandemic had a significant impact on the global actinic keratosis treatment market. Due to the imposition of the lockdown, people were not able to go for proper diagnosis and treatment of actinic keratosis. As a result, the cases became severe and turned into squamous cell carcinoma, a skin cancer. Additionally, the lack of availability of diagnosis and health workers involvement majorly in the cause of the spread of the disease impacted the market. This caused a decline in the growth of the global actinic keratosis treatment market.
A full report of Global Actinic Keratosis Treatment Market Size available @ https://www.omrglobal.com/industry-reports/actinic-keratosis-treatment-market-share
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Actinic Keratosis Treatment Market by Type
- Medication
- Fluorouracil
- Imiquimod
- Ingenol Mebutate
- Others
- Therapy
- Photodynamic Therapy
- Laser Surgery
- Others (Combination Therapy)
Global Actinic Keratosis Treatment Market by End-User
- Hospitals & Oncology Centers
- Dermatology Clinics
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Athenex, Inc.
- Biofrontera Inc.
- BioLineRx Ltd.
- Cipher Pharmaceuticals Inc.
- Galderma SA
- Hill Dermaceuticals Inc.
- Leo Pharma A/S
- Mylan Pharmaceuticals Pvt. Ltd.
- Stanford Chemical Co.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Valeant Pharmaceuticals Inc.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global actinic keratosis treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/actinic-keratosis-treatment-market-share
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
